AACI Update | May 2021

Headlines

Knudsen to Step Down as AACI President

Knudsen to Step Down as AACI President

AACI President Karen E. Knudsen, MBA, PhD, is resigning from Sidney Kimmel Cancer Center (SKCC) at Jefferson Health in Philadelphia. She will step down as AACI president and begin her new role as chief executive officer of the American Cancer Society (ACS) on Tuesday, June 1. Dr. Knudsen will be the first woman CEO to lead the 107-year-old organization and the American Cancer Society Cancer Advocacy Network (ACS CAN).

Read More

Holcombe Named Director of UVMCC

Holcombe Named Director of UVMCC

Randall F. Holcombe, MD, MBA, has been appointed director of The University of Vermont Cancer Center (UVMCC) and chief of the Division of Hematology and Oncology in the Department of Medicine. He joins UVMCC from the National Cancer Institute (NCI)-Designated University of Hawai'i Cancer Center, where he has served as director since 2016. Dr. Holcombe will begin his tenure on August 1. He succeeds Richard Galbraith, MD, PhD, and Chris Holmes, MD, PhD, who became interim co-directors of UVMCC in 2020.

Read More

Reps. Higgins, Bilirakis to Receive Cancer Research Ally Award

Reps. Higgins, Bilirakis to Receive Cancer Research Ally Award

Representatives Brian Higgins (D-NY) and Gus Bilirakis (R-FL) will be honored with the Cancer Research Ally Award at the 2021 AACI/AACR Hill Day, which will be held virtually on June 9. Both congressmen will deliver remarks as part of the event’s lunchtime programming.

Read More

CRI Keynote Spotlight: Mary 'Dicey' Jackson Scroggins

CRI Keynote Spotlight: Mary 'Dicey' Jackson Scroggins

Mary "Dicey" Jackson Scroggins, MA, will deliver the keynote presentation on Wednesday, July 14 during the 13th Annual AACI CRI Meeting. Scroggins, a 24-year ovarian cancer survivor and recent acute myeloid leukemia (AML) survivor, research advocate, and health activist, is driven by a commitment to global health equity.

Read More

Call for Nominations: AACI Cancer Health Equity Award

Nominations are now being accepted for the 2021 AACI Cancer Health Equity Award. The award was created to recognize an individual or group who demonstrates exceptional leadership in promoting health equity, mitigating cancer disparities, and advocating for diversity and inclusion at their cancer center. The nomination period will close on Friday, May 28.

Read More

Reminder: Promote Your Cancer Center With a CRI Meeting Program Ad

Reminder: Promote Your Cancer Center With a CRI Meeting Program Ad

AACI invites you to promote your cancer center by purchasing an ad in the 13th Annual AACI CRI Meeting program. The digital program book offers an excellent opportunity to showcase your center while supporting the CRI meeting. Your cancer center’s program ad may highlight a conference or a new initiative, or celebrate the success of the center’s clinical trials office. Cancer centers may also include links to their website and any upcoming events.

Read More

News from the Centers

Beckerle Elected to National Academy of Sciences

Beckerle Elected to National Academy of Sciences
Huntsman Cancer Institute, University of Utah

The National Academy of Sciences has elected Mary Beckerle, PhD, Huntsman Cancer Institute CEO and distinguished professor of biology and oncological sciences at the University of Utah, as a member. Dr. Beckerle is among 120 newly elected members of the academy.

Read More

Maquat Awarded 2021 Wolf Prize in Medicine

Maquat Awarded 2021 Wolf Prize in Medicine
Wilmot Cancer Institute, UR Medicine

Lynne E. Maquat, PhD, the founding director of the Center for RNA Biology at the University of Rochester, has been honored with the 2021 Wolf Prize in Medicine. She shares the award with Joan Steitz, PhD, at Yale School of Medicine, and Adrian Krainer, PhD, at Cold Spring Harbor Laboratory.

Read More

Gordon Receives Kober Medal

Gordon Receives Kober Medal
Siteman Cancer Center

Jeffrey I. Gordon, MD, has been awarded the George M. Kober Medal from the Association of American Physicians in recognition of his contributions to the field of gut microbiome research. Dr. Gordon, a research member of Siteman Cancer Center, is considered to be the father of the field.

Read More

Sharifi Honored With AACR Achievement Award

Sharifi Honored With AACR Achievement Award
Case Comprehensive Cancer Center

The Case Comprehensive Cancer Center congratulates the Cleveland Clinic's Nima Sharifi, MD, on his selection as the 2021 recipient of the American Association for Cancer Research (AACR) Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research.

Read More

Balderson Leads National Physician Assistants Organization

Balderson Leads National Physician Assistants Organization
Duke Cancer Institute, Duke University Medical Center

Duke Cancer Institute physician assistant Scott Balderson, PA-C, has begun his term as president of the national Association of Physician Assistants in Cardiothoracic and Vascular Surgery. The association has more than 700 members and supports advocacy, medical education, and professional recertification.

Read More

Chi Receives Kastan Award

Chi Receives Kastan Award
Duke Cancer Institute, Duke University Medical Center

The American Association for Cancer Research has named Jen-Tsan Ashley Chi, MD, PhD, as co-winner of the Molecular Cancer Research Michael B. Kastan Award for Research Excellence on behalf of his all-Duke research team for their paper, "A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer."

Read More

White Elected as a Fellow to the AACR Academy

White Elected as a Fellow to the AACR Academy
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey deputy director, Eileen White, PhD, has been elected to the 2021 class of Fellows of the American Association for Cancer Research (AACR) Academy.

Read More

Back to News From the Centers

$10 Million Gift to Support Research Initiatives, New Director

$10 Million Gift to Support Research Initiatives, New Director
The University of Chicago Medicine Comprehensive Cancer Center

A $10 million grant from the AbbVie Foundation will support scientific and educational activities at the University of Chicago Medicine Comprehensive Cancer Center under the leadership of newly appointed director, Kunle Odunsi, MD, PhD.

Read More

$6 Million Awarded to Decrease Disparities in Cancer Clinical Trials

$6 Million Awarded to Decrease Disparities in Cancer Clinical Trials
The Tisch Cancer Institute at Mount Sinai

Mount Sinai researchers have received a grant award to lead a collaborative team of New York institutions in an initiative that addresses disparities in the participation of Black, indigenous, and people of color in cancer clinical trials. Stand Up To Cancer® awarded $6 million to a multi-institutional team that will be led by Nina Bickell, MD, MPH.

Read More

$3 Million Grant Awarded to Apply AI to Lung Cancer Immunotherapy

Case Comprehensive Cancer Center

Researchers from Case Western Reserve University, New York University, and University Hospitals have been awarded a five-year, $3 million National Cancer Institute grant to develop and apply artificial intelligence (AI) tools for predicting which lung cancer patients will respond to immunotherapy.

Read More

Advances in Brain Cancer Research Lead to $3 Million Award

Advances in Brain Cancer Research Lead to $3 Million Award
Cancer Center at Illinois

Several Cancer Center at Illinois members are joining forces with scientists from the Mayo Clinic and Georgetown University on an expansive project targeting improved treatment for glioblastoma. The team, led by Brendan Harley, PhD, recently received a $3 million grant from the National Cancer Institute for their research.

Read More

Maihle Wins DOD Award

Maihle Wins DOD Award
UMMC Cancer Center and Research Institute

A $2.7 million U.S. Department of Defense Ovarian Cancer Academy Leadership Award has been awarded to Nita Maihle, PhD. She shares the award with Douglas Levine, MD, a gynecologic oncologist at New York University.

Read More

Roswell Park, Wilmot Partner on First Large Study of Immunotherapy in Black Cancer Patients

Roswell Park Comprehensive Cancer Center

Funded by a two-year, $2.08 million grant from the National Cancer Institute, a new collaboration between two western New York cancer research leaders will help oncologists learn whether Black and white cancer patients respond differently to a game-changing immunotherapy treatment.

Read More

Seed Grant Leads to $1.25 Million NIH Grant for Breast Cancer Research

Seed Grant Leads to $1.25 Million NIH Grant for Breast Cancer Research
Cancer Center at Illinois

In 2019, Cancer Center at Illinois (CCIL) member Prasanth Kumar V. Kannanganattu, PhD, received a $250,000 CCIL Seed Grant to support his research on the characterization of oncogenic noncoding RNAs in breast cancer progression and metastasis. The project has now been further funded by a $1.25 million National Institutes of Health (NIH) Research Grant.

Read More

Award to Jump-Start Young Scientists Seeking to Cure Cancer

Cedars-Sinai Cancer

Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer, and Peter Kuhn, PhD, director of the Convergent Science Institute in Cancer at the USC Michelson Center for Convergent Bioscience, have received the inaugural Virtual Cancer Center Director Award to establish the Convergent Science Virtual Cancer Center. The center will guide emerging scholars from diverse science backgrounds and institutions to accelerate their research and careers.

Read More

Back to News From the Centers

Associate Director for Cancer Equity Announced

Associate Director for Cancer Equity Announced
USC Norris Comprehensive Cancer Center

Chanita Hughes-Halbert, PhD, will join USC Norris Comprehensive Cancer Center as associate director for cancer equity, a newly created position. Her appointment begins July 1 and she joins USC from the Medical University of South Carolina.

Read More

Juckett Named CTO-CGI Medical Director

Juckett Named CTO-CGI Medical Director
Masonic Cancer Center, University of Minnesota

Mark Juckett, MD, was appointed medical director of the Masonic Cancer Center Clinical Trials Office for the Cellular, Gene and Immunotherapy Initiative (CTO-CGI), succeeding Shernan Holtan, MD, who initiated the role. Dr. Juckett was recruited from the University of Wisconsin - Madison.

Read More

Zheng Named Associate Director for Population Sciences Research

Zheng Named Associate Director for Population Sciences Research
Vanderbilt-Ingram Cancer Center

Wei Zheng, MD, PhD, MPH, has been named associate director for Population Sciences Research at Vanderbilt-Ingram Cancer Center. He replaces William Blot, PhD, who retired from the leadership position on April 1.

Read More

Kelly Named Associate Director for Cancer Research Training and Education

Kelly Named Associate Director  for Cancer Research Training and Education
UAMS Winthrop P. Rockefeller Cancer Institute

Thomas J. Kelly Jr., PhD, has been named associate director for cancer research training and education at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS). Dr. Kelly is an associate professor of pathology in the UAMS College of Medicine Department of Pathology and will become a full professor in July.

Read More

New Chief of Hematology/Oncology Named

New Chief of Hematology/Oncology Named
UPMC Hillman Cancer Center

Taofeek K. Owonikoko, MD, PhD, will join the UPMC Hillman Cancer Center and Department of Medicine at the University of Pittsburgh as chief of the Division of Hematology/Oncology. He also will serve as associate director for translational research and co-leader of the Cancer Therapeutics Program at Hillman.

Read More

Lu Named EDT Co-Program Leader

Lu Named EDT Co-Program Leader
Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Xiongbin Lu, PhD, has been named co-program leader of the Experimental and Developmental Therapeutics (EDT) research program. He has made important discoveries promoting translational development of human cancer research, including breast cancer targeted therapy and immunotherapy.

Read More

Mohan Joins Moffitt as New Vice President of Digital

Mohan Joins Moffitt as New Vice President of Digital
Moffitt Cancer Center

Santosh Mohan, MMCi, CPHIMS, FHIMSS, has joined Moffitt Cancer Center as the new vice president of digital. This newly created position will be instrumental in Moffitt’s success as the cancer center accelerates its digital capabilities to advance cancer care, treatment, and research.

Read More

Physician-Researcher Tapped to Lead Cancer Genetics and Genomics Department

Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center has appointed Agnes Witkiewicz, MD, as director of cancer genetics and genomics. She will also hold the John & Santa Palisano Endowed Chair of Cancer Genetics.

Read More

Sacks Named Division Director in Plastic and Reconstructive Surgery

Sacks Named Division Director in Plastic and Reconstructive Surgery
Siteman Cancer Center

Justin M. Sacks, MD, has been named director of the Division of Plastic and Reconstructive Surgery at Washington University School of Medicine in St. Louis. Dr. Sacks will treat patients at Siteman Cancer Center.

Read More

Faculty Leader Named for Cancer Therapy Discovery and Development

Faculty Leader Named for Cancer Therapy Discovery and Development
University of Wisconsin Carbone Cancer Center

Nataliya Uboha, MD, PhD, has been selected to lead the Cancer Therapy Discovery and Development program at the University of Wisconsin Carbone Cancer Center.

Read More

Markham Appointed as Chief of Hematology and Oncology

Markham Appointed as Chief of Hematology and Oncology
University of Florida Health Cancer Center

Merry Jennifer Markham, MD, FACP, FASCO, has been appointed as chief of the division of hematology and oncology in the UF College of Medicine. Dr. Markham has served as the associate director for medical affairs for the UF Health Cancer Center since 2017.

Read More

Senior Director of Clinical Research Innovation Appointed

Senior Director of Clinical Research Innovation Appointed
Huntsman Cancer Institute, University of Utah

Neeraj Agarwal, MD, a physician-scientist at Huntsman Cancer Institute, has been appointed senior director of clinical research innovation, overseeing critical components of Huntsman's clinical research infrastructure.

Read More

Back to News From the Centers

Study Analyzes Clinical, Economic Impact of Hemorrhagic Cystitis in Stem Cell Transplant Patients

Study Analyzes Clinical, Economic Impact of Hemorrhagic Cystitis in Stem Cell Transplant Patients
The University of Kansas Cancer Center

A study led by The University of Kansas Cancer Center, with AlloVir, Certara, and Memorial Sloan Kettering Cancer Center, compares the economic burden, health resource utilization, and clinical outcomes among allogeneic hematopoietic stem cell transplant recipients with virus-associated hemorrhagic cystitis to those without virus-associated hemorrhagic cystitis. Joseph McGuirk, DO, is lead author.

Read More

Study: Jump in Cancer Diagnoses at 65 Implies Patients Wait for Medicare

Stanford Cancer Institute

A new study has found a substantial rise nationwide in new diagnoses at age 65 for lung, breast, colon, and prostate cancer, suggesting that many wait for Medicare to kick in before they seek care.

Read More

Having a Single Personal Doctor May Sometimes Lead to Unnecessary Tests

University of Florida Health Cancer Center

A new University of Florida study finds that male patients who have a single general physician were more likely to receive a prostate cancer screening test during a period when the test was not recommended by the U.S. Preventive Services Task Force.

Read More

Drug Derived From Kentucky-Grown Plant Shows Promise for Ovarian Cancer Treatment

UK Markey Cancer Center

A new study from UK Markey Cancer Center researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.

Read More

New CRISPR Technology Offers Unrivaled Control of Epigenetic Inheritance

UCSF Helen Diller Family Comprehensive Cancer Center

In a new paper, researchers at UC San Francisco and the Whitehead Institute describe a CRISPR-based tool called "CRISPRoff," which allows scientists to switch off almost any gene in human cells without making a single edit to the genetic code.

Read More

Patients With Metastatic Breast Cancer and High Mutational Burden Benefit From Pembrolizumab

University of Michigan Rogel Cancer Center

The immunotherapy agent pembrolizumab can provide clinical benefit to some patients with metastatic breast cancer whose tumors were found to have a high number of mutations, and whose cancer continued to progress with standard treatments.

Read More

Protein Identified That Could Serve as Therapeutic Target in Lung Cancer

VCU Massey Cancer Center

Scientists at VCU Massey Cancer Center have identified a protein that operates in tandem with a specific genetic mutation to spur lung cancer growth and could serve as a therapeutic target to treat the disease.

Read More

Bone Microenvironment Fosters Breast Cancer Metastatic Behavior

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine

Two studies led by Baylor College of Medicine shed new light on the unanswered question of why estrogen receptor-positive (ER+) breast cancer sometimes grows back in the bone and spreads to other tissues despite effective endocrine therapies directed at ER.

Read More

New Research Suggests Breast Cancer Treatment in Patients Over Age 70 Can Be Safely Reduced

UPMC Hillman Cancer Center

A study by researchers at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine suggests the rate of cancer recurrence or survival may be no different in treated versus untreated elderly patients diagnosed in the early stages of breast cancer.

Read More

Study Revises Understanding of Cancer Metabolism

Vanderbilt-Ingram Cancer Center

Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years.

Read More

Discovery Could Revive Failed Treatments for Solid Tumors

Discovery Could Revive Failed Treatments for Solid Tumors
University of Virginia Cancer Center

New research from the UVA Cancer Center’s Jogender Tushir-Singh, PhD, could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon, and triple-negative breast cancer, that ultimately failed in human clinical trials.

Read More

Information Theory Recruited to Help Scientists Find Cancer Genes

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

Using a field of mathematics designed mainly to study how digital and other forms of information are measured, stored, and shared, scientists at Johns Hopkins Medicine and Johns Hopkins Kimmel Cancer Center say they have uncovered a likely key genetic culprit in the development of acute lymphoblastic leukemia.

Read More

New CAR T Approach Minimizes Resistance, Helps Avoid Relapse in Non-Hodgkin's B-Cell Lymphoma

UCLA Jonsson Comprehensive Cancer Center

Early results from a chimeric antigen receptor (CAR) T cell immunotherapy trial led by researchers at the UCLA Jonsson Comprehensive Cancer Center found using a bilateral attack instead of the conventional single-target approach helps minimize treatment resistance, resulting in long-lasting remission for people with non-Hodgkin's B-cell lymphoma that has returned or not responded to treatment.

Read More

Genetic Diversity Within Tumors Suggests Continuous Evolution

The University of Texas MD Anderson Cancer Center

Analyzing tumors from more than 2,600 patients and 38 cancer types, researchers from The University of Texas MD Anderson Cancer Center and the international Pan-Cancer Analysis of Whole Genomes Consortium have characterized the extensive genetic diversity across cancer and within individual tumors.

Read More

Liquid Biopsy Test Developed for Lymph Node Metastasis in Early-Stage T1 Colorectal Cancer

City of Hope Comprehensive Cancer Center

Scientists at City of Hope have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma.

Read More

Project Explores Text Messages for Smoking Cessation

Wilmot Cancer Institute, UR Medicine

A Wilmot Cancer Institute team is launching a two-year research project to develop different types of text messages for smoking cessation, and then study them in clinical trials to find out what works best.

Read More

Black Prostate Cancer Patients Face Higher Risk of Cardiovascular Disease-Related Mortality Than White Patients

Sidney Kimmel Cancer Center at Jefferson Health

Cardiovascular disease-related mortality among prostate cancer patients is significantly higher among Black patients compared with white patients, according to research from the Sidney Kimmel Cancer Center at Jefferson Health.

Read More

New Method Developed for Identifying Mutational Signatures in Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

Researchers at the Johns Hopkins Kimmel Cancer Center used machine learning techniques to detect mutational signatures in cancer patients. Their algorithm outperformed the current standard of analysis and revealed new mutational signatures associated with obesity.

Read More

End-of-Life Care Remains Aggressive for People With Ovarian Cancer

University of Michigan Rogel Cancer Center

People with ovarian cancer frequently receive aggressive end-of-life care despite industry guidelines that emphasize quality of life for those with advanced disease, according to a recent study.

Read More

Investigators Identify STING Gene Methylation Allows Melanoma to Evade the Immune System

Moffitt Cancer Center

In a new article, Moffitt Cancer Center researchers demonstrate how an important defect in STING gene expression in melanoma cells contributes to their evasion from immune cell detection and destruction.

Read More

Pancreatic Cancer Cells Hijack Muscle Protein to Beef Up Their Metabolism

UCSF Helen Diller Family Comprehensive Cancer Center

Cancer starts with mutations in a cell’s DNA, but new UC San Francisco research shows that the endurance of a tumor relies on its ability to rapidly evolve and adapt to challenges brought about by the environment in which it grows.

Read More

Stem Cell Transplants Prevent Relapses of Most Common Childhood Cancer

University of Virginia Cancer Center

Children and young adults who receive CAR T-cell therapy for acute lymphoblastic leukemia suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds.

Read More

Genomic Data Commons Provides Unprecedented Cancer Data Resource

The University of Chicago Medicine Comprehensive Cancer Center

The National Cancer Institute’s Genomic Data Commons, launched in 2016 by then-Vice President Joseph Biden and hosted at the University of Chicago, has become one of the largest cancer genomics resources, with more than 3.3 petabytes of data from more than 65 projects and over 84,000 anonymized patient cases.

Read More

New Strategy Found for Fighting Brain Cancer

VCU Massey Cancer Center

VCU Massey Cancer Center researcher Suyun Huang, PhD, recently discovered how cholesterol becomes dysregulated in brain cancer cells and showed that the gene responsible for it could be a target for future drugs.

Read More

Study Reveals a Unique Mode of Cell Migration on Soft Viscoelastic Surfaces

Stanford Cancer Institute

To advance studies of cell migration, Stanford researchers have worked to develop and test new types of material that closely imitate the real tissue that surrounds cells.

Read More

Study Suggests Common Drug Could Be Used to Prevent Certain Skin Cancers

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

New data published by researchers at OSUCCC – James suggests that an oral drug currently used to treat neuromuscular diseases could also help prevent squamous cell skin cancer.

Read More

Back to News From the Centers

Arizona Clinical Trials Network Launched

The University of Arizona Cancer Center

Arizona residents, including underserved and underrepresented populations, will have better access to cutting-edge cancer therapies as the University of Arizona Cancer Center offers its clinical trials at locations across the state. The network is a collaboration among communities, hospitals, and physicians that will enable the university’s clinical research to reach more patients.

Read More

Sameer Patel Co-Authors New Textbook on Cosmetic Breast Surgery

Sameer Patel Co-Authors New Textbook on Cosmetic Breast Surgery
Fox Chase Cancer Center, Temple Health

Sameer Patel, MD, FACS, chief of the Division of Plastic and Reconstructive Surgery in the Department of Surgical Oncology at Fox Chase Cancer Center and the Temple University Health System, has co-authored a new textbook, Cosmetic Breast Surgery.

Read More

New Initiative to Increase Patient Engagement

Fox Chase Cancer Center, Temple Health

Fox Chase Cancer Center has begun utilizing a new program called MyCareCompass that is designed to support patients with necessary information about their care by sending that information directly to them.

Read More

Study Seeks to Understand Effectiveness of COVID-19 Vaccination in Cancer Patients, Survivors

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

A study at OSUCCC - James will evaluate how COVID-19 impacts the immune system of cancer patients. The study will look at whether the COVID-19 vaccine is less effective in cancer patients receiving certain therapies, and how long immunity lasts.

Read More

UAMS Surpasses 100,000 Digital Health Visits in Pandemic

UAMS Winthrop P. Rockefeller Cancer Institute

The University of Arkansas for Medical Sciences conducted more than 100,000 digital health visits following the COVID-19 outbreak, seeing its highest numbers of virtual consultations at the height of the pandemic and during a February winter storm, performing more than 4,500 digital health visits per week.

Read More

Back to News From the Centers

Cancer Center Jobs

Project Coordinator, Site Operations
Fred Hutchinson Cancer Research Center
Read more
Research Administrator
Cleveland Clinic Cancer Center
Read more
Chair, Taussig Cancer Institute
Cleveland Clinic Cancer Center
Read more
Clinical Trials Amendment Manager
Moffitt Cancer Center
Read more
CAR T Research Nurse
Stony Brook Cancer Center
Read more
Director, Oncology and Pediatric Clinical Research Operations
Moffitt Cancer Center
Read more
FDA Regulatory Specialist
OHSU Knight Cancer Institute
Read more
Regulatory Affairs Associate
Fred Hutchinson Cancer Research Center
Read more
Regulatory Coordinator, Cancer Clinical Trials
Stony Brook Cancer Center
Read more
Research Phlebotomist Cancer Clinical Trials
Stony Brook Cancer Center
Read more
Study Coordinator Cancer Clinical Trials
Stony Brook Cancer Center
Read more
Data Quality Manager
Dana-Farber Cancer Institute, Harvard Medical School
Read more
Director of Oncology and Pediatric Clinical Research
Moffitt Cancer Center
Read more
Program Administrator
Sanford Burnham Prebys Medical Discovery Institute
Read more
Senior Program Analyst
The University of Arizona Cancer Center
Read more
AMPATH Hematology-Oncology Team Leader
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Read more
Clinical Trial Activation Project Manager (2 Positions)
UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Read more
Vice President, Cancer Services
Dartmouth-Hitchcock Norris Cotton Cancer Center
Read more
Back to top